Health Care: Drugs

Orexigen Therapeutics Inc. (OREX: NASDAQ)

$6.19 0.08 | 1.31%
05/22/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 3.43M 4.40M 1.23M 88.00K
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 3.43M 4.40M 1.23M 88.00K
Selling, General, and Administrative Expenses 19.99M 19.50M 24.50M 18.18M
Research & Development 73.68M 12.78M 28.13M 47.44M
Operating Income before D & A (EBITDA) -90.24M -27.88M -51.40M -65.53M
Depreciation & Amortization 813.00K 1.50M 1.79M 1.54M
Interest Income 147.00K 46.00K 124.00K 333.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -90.90M -29.34M -53.06M -66.74M
Interest Expense 2.00K 221.00K 644.00K 1.36M
Pre-Tax Income -90.91M -29.56M -53.71M -68.10M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -90.09M 0.00 0.00 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -90.09M 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -90.09M -28.06M -51.92M -66.56M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -90.09M 0.00 0.00 0.00
Preferred Dividends
Net Income Available To Common -90.09M 0.00 0.00 0.00
Basic EPS from Continuing Ops. -1.27 -0.58 -1.10 -1.67
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.27 -0.58 -1.10 -1.67
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.27 -0.58 -1.10 -1.67
Basic Normalized Net Income/Share -1.27 n.a. n.a. n.a.
EPS fr Continuing Ops. -1.27 -0.58 -1.10 -1.67
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.27 -0.58 -1.10 -1.67
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.27 -0.58 -1.10 -1.67
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -1.27 n.a. n.a. n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with OREX

View All

Latest OREX Headlines from TheStreet

More Financial News for OREX

Press Releases for OREX

See All Press Releases

Partner Headlines for OREX

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter